Back to search results

Establishing Biomarkers and Clinical Endpoints in Myotonic Dystrophy Type 1 (END-DM1) Extension

Abroad (travel likely)Recruiting

Conditions

DM1 · Myotonic Dystrophy · Myotonic Dystrophy 1 · Myotonic Dystrophy Type 1 · Myotonic Dystrophy Type-1 · Myotonic Dystrophy, Type 1 (DM1) · Myotonic Muscular Dystrophy

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Virginia Commonwealth University, Richmond, Virginia, United States

    Contact: Study coordinator (Jennifer Raymond) · Jennifer.raymond@vcuhealth.org · 804-828-6318
    Contact: Principal Investigator (Nicholas Johnson, MD)
Study leads

  • Nicholas Johnson, MD

    Principal Investigator

    Virginia Commonwealth University

View source on ClinicalTrials.gov(opens in a new tab)